CBA 2018 Annual Conference

Date: October 6, 2018 @ 8:00 am – @ 5:00 pm
Location: Crowne Plaza, Foster City, CA

CBA 2018 Annual Conference

Theme: Building Bridges to Biotech Innovations

Conference Highlight:

  • Keynote presentations from Dr. Mien-Chie Hung (VP of MD Anderson Cancer Center), Wei Wang (President, Sinopharm Group) and Dr. Timothy Lu (Associate Professor, MIT)
  • New trends of regulatory considerations in both US and China
  • Special talk from FDA officer
  • Digital Health and Big Data
  • Investment and Entrepreneurship
  • Expected to attract more than 300 attendees from bioscience and biopharma industries
  • Networking opportunities with life science professionals and potential clients
  • On-site recruitment (Simcere, 先声药业)

Registration: https://www.eventbrite.com/e/cba-2018-annual-conference-tickets-49057123176

Please use the promo code “cabs5off” to get a $5 off for your ticket.

Conference Ticket Price:

Breakfast, lunch and event reception are included in the ticket.

Ticket types

Early Bird

(by 9/29/2018)

Regular

(9/29/2018 – 10/5/2018)

On-site

(10/6/2018)

CBA Member

$35

$55

$80

Non-member

$55

$75

$100

Student (with .edu email)

$10

$10

$30

Conference Agenda:

8:00 – 8:30 am

Registration, Networking, and Exhibitions

8:30 – 8:35 am

Welcome and Opening Remarks

Mark Chen, Ph.D., CBA president

8:35 – 8:40 am

Conference Introduction

Thomas Wei, Ph.D., CBA Conference Chair

Morning Keynote Presentation (Moderators: Mark Chen and Lin Sun-Hoffman)

8:40 – 9:20 am

Marker-guided targeted therapy, PARP inhibitors, and immune checkpoint therapy

Mien-Chie Hung, Ph.D. (Basic Research VP, MD Anderson Cancer Center, The University of Texas)

9:20 – 10:00 am

Entrepreneurship in China

Wei Wang (Sinopharm Group, President)

*Interpreter: Tom Zhang

10:00 – 10:15 am

Networking and Exhibitions

Session I: Drug Regulation (Moderator: Kai Zheng)

10:15 – 10:45 am

Regulatory considerations in the IND submission of antibody and related products

Audrey Jia, Ph.D. (Principal Consultant, DataRevive LLC)

10:45 am – 11:15 am

Regulatory consideration for clinical development in product life cycle management

Ardelle Ying, Ph.D. (Program Director, Genentech)

11:15 am – 11:45 am

Accelerate new drug development: Paradigm shift in the post-ICH regulatory systems in China, and US 

Dan Zhang, Ph.D. (Chairman and CEO, Fountain Medical Development Ltd)

Special Talk (Introduced by: Huifang Li)

11:45 am – 12:15 pm

Career Development for Life – IQ, EQ, and SQ / Career Opportunities in the FDA

George Chang, Ph.D.(Senior Pharmacologist, FDA)

12:15 pm– 12:25pm

Sponsor Presentation (Eirgenix)

12:25 – 1:15 pm

Lunch, Networking and Exhibitions

1:15 – 1:25 pm

CBA Scholarship Award

Afternoon Keynote Presentation (Introduced by: Thomas Wei)

1:25 – 2:05pm

Engineering Biological Computers for Human Health Applications

Timothy Lu, Ph.D. (Associate Professor, MIT)

Session II: Digital Health and Big Data (Moderator: Michelle Chen)

2:05 – 2:35pm

Online dermatology transition from dermatologists to artificial intelligence

Alexander Börve, MD (Founder & CEO, First Derm)

2:35 – 3:05pm

Genomic revolution and blockchain

Huijun Zhou, Ph.D. (Co-founder, Doctor Chain)

3:05 – 3:35pm

Using Genomic Features to Make Smart Clinical Decisions: the Power of Machine Learning and RNA-seq

Jing Huang, Ph.D. (SVP of Bioinformatics and Data Science, Veracyte Inc.)

3:35 – 3:50pm

Networking and Exhibitions

3:50 – 4:50pm

Investment and Entrepreneurship Panel Discussion

(Moderator: Lin Sun-Hoffman)

Jo Shen, Ph.D. (Vivo Capital)

Keting Chu, Ph.D.(Lyfe Venture)

Jimmy Zhang, Ph.D. MBA (Lily Asia Venture)

Guoliang Yu, Ph.D. (Global CEO of CBT Pharmaceuticals)

4:50 – 4:55 pm

Closing Remarks

Thomas Wei, Ph.D., CBA Conference Chair

5:00 – 7:00 pm

Evening Reception

Registration: https://www.eventbrite.com/e/cba-2018-annual-conference-tickets-49057123176

Please use the promo code “cabs5off” to get a $5 off for your ticket.

 

RSVP – $0 (USD)

.